<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Effects of hyperbaric oxygen therapy on the expression levels of the inflammatory factors interleukin-12p40, macrophage inflammatory protein-1β, platelet-derived growth factor-BB, and interleukin-1 receptor antagonist in keloids.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Effects of hyperbaric oxygen therapy on the expression levels of the inflammatory factors interleukin-12p40, macrophage inflammatory protein-1β, platelet-derived growth factor-BB, and interleukin-1 receptor antagonist in keloids." class="clickable-image" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8861/7220187/b5a612d95eb0/medi-99-e19857-g002.jpg"/> </div> <div class="text-side"> <h1>Effects of hyperbaric oxygen therapy on the expression levels of the inflammatory factors interleukin-12p40, macrophage inflammatory protein-1β, platelet-derived growth factor-BB, and interleukin-1 receptor antagonist in keloids.</h1> <p>The results of epidermal and dermal H&amp;E staining. The number of infiltrated cells (red arrow) was much lower in the A group and the C group than in the B group (images: 200×). A group = keloid samples from keloid patients treated with HBO therapy, B group = keloid samples from keloid patients treated without HBO therapy, C group = normal skin samples from patients without obvious scarring, H&amp;E = hematoxylin and eosin.</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32312010/" target="_blank">32312010</a></p><p>Type: Benign, Category: Fibrohistiocytic</p>
</div> </div></div></body></html>